198 related articles for article (PubMed ID: 11108892)
1. Progesterone receptor modulators and progesterone antagonists in women's health.
Spitz IM; Chwalisz K
Steroids; 2000; 65(10-11):807-15. PubMed ID: 11108892
[TBL] [Abstract][Full Text] [Related]
2. Progesterone antagonists and progesterone receptor modulators: an overview.
Spitz IM
Steroids; 2003 Nov; 68(10-13):981-93. PubMed ID: 14667991
[TBL] [Abstract][Full Text] [Related]
3. The use of progesterone antagonists and progesterone receptor modulators in contraception.
Spitz IM; Van Look PF; Coelingh Bennink HJ
Steroids; 2000; 65(10-11):817-23. PubMed ID: 11108893
[TBL] [Abstract][Full Text] [Related]
4. Progesterone antagonists and progesterone receptor modulators.
Spitz IM
Expert Opin Investig Drugs; 2003 Oct; 12(10):1693-707. PubMed ID: 14519088
[TBL] [Abstract][Full Text] [Related]
5. Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity.
Elger W; Bartley J; Schneider B; Kaufmann G; Schubert G; Chwalisz K
Steroids; 2000; 65(10-11):713-23. PubMed ID: 11108882
[TBL] [Abstract][Full Text] [Related]
6. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications.
Chabbert-Buffet N; Meduri G; Bouchard P; Spitz IM
Hum Reprod Update; 2005; 11(3):293-307. PubMed ID: 15790602
[TBL] [Abstract][Full Text] [Related]
7. Effects of antiprogestins on the uterus.
Ouzounian S; Bouchard P; Chabbert-Buffet N
Womens Health (Lond); 2008 May; 4(3):269-80. PubMed ID: 19072476
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor antagonists.
Spitz IM
Curr Opin Investig Drugs; 2006 Oct; 7(10):882-90. PubMed ID: 17086932
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium.
Chwalisz K; Brenner RM; Fuhrmann UU; Hess-Stumpp H; Elger W
Steroids; 2000; 65(10-11):741-51. PubMed ID: 11108885
[TBL] [Abstract][Full Text] [Related]
10. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health.
Olive DL
Obstet Gynecol Surv; 2002 Nov; 57(11 Suppl 4):S55-63. PubMed ID: 12454529
[TBL] [Abstract][Full Text] [Related]
11. [Selective progesterone receptor modulators and their therapeutical use].
Driák D; Sehnal B; Svandová I
Ceska Gynekol; 2013 Apr; 78(2):175-81. PubMed ID: 23710982
[TBL] [Abstract][Full Text] [Related]
12. Selective progesterone receptor modulators: current applications and perspectives.
Chabbert-Buffet N; Kolanska K; Daraï E; Bouchard P
Climacteric; 2018 Aug; 21(4):375-379. PubMed ID: 29338440
[TBL] [Abstract][Full Text] [Related]
13. Antiprogestins: mechanism of action and contraceptive potential.
Spitz IM; Croxatto HB; Robbins A
Annu Rev Pharmacol Toxicol; 1996; 36():47-81. PubMed ID: 8725382
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 11' imidazolyl antiprogestins and mesoprogestins.
Nickisch K; Elger W; Santhamma B; Garfield R; Killeen Z; Amelkina O; Schneider B; Meister R
Steroids; 2014 Dec; 92():45-55. PubMed ID: 25174783
[TBL] [Abstract][Full Text] [Related]
15. Antigestogens.
Baird DT
Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
[TBL] [Abstract][Full Text] [Related]
16. Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer.
Klijn JG; Setyono-Han B; Foekens JA
Steroids; 2000; 65(10-11):825-30. PubMed ID: 11108894
[TBL] [Abstract][Full Text] [Related]
17. Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
Talaulikar VS; Manyonda I
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):135-40. PubMed ID: 22901974
[TBL] [Abstract][Full Text] [Related]
18. Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century.
Spitz IM
Contraception; 2010 Nov; 82(5):442-52. PubMed ID: 20933118
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
Kannan A; Bhurke A; Sitruk-Ware R; Lalitkumar PG; Gemzell-Danielsson K; Williams ARW; Taylor RN; Bagchi MK; Bagchi IC
Reprod Sci; 2018 Mar; 25(3):320-328. PubMed ID: 29241443
[TBL] [Abstract][Full Text] [Related]
20. Selective progesterone receptor modulators: new possibilities for gynecologic hormone therapy.
Sarvilinna N; Unkila-Kallio L; Härkki P; Tiitinen A; Heikinheimo O
Duodecim; 2017; 133(1):27-33. PubMed ID: 29199806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
